Advanced neurobiology modeling with stem cells

Live Webinar from Qkine

Our partner Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins for stem cell and organoid culture. Based in Cambridge, UK, Qkine combines proprietary production processes with protein engineering technology to tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cultured meat sectors.

Join Qkine's live webinar on neurobiology modeling with stem cells.

Webinar: Advanced neurobiology modeling with stem cells

Advancement in neuroscience research is challenged by the availability of physiologically relevant in vitro models that accurately recapitulate the complexity of the neural tissue. Stem-cell-based neural models have gained significant interest for their potential in several biomedical applications from regenerative medicine to drug discovery and development.

In this webinar on advanced neurobiology modelling with stem cells, our speakers will present innovative ways of using induced pluripotent stem cells to effectively model neurodevelopment and neurodegenerative diseases, thereby overcoming the limitations seen with present neurobiological models. There will also be an opportunity to learn from industry experts about innovation in growth factor technology to improve reproducibility in neural stem cell research and other related applications.

Learning Objectives:

Understanding neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy
Recognizing the limitation of current models for neurodevelopment and neurodegenerative diseases
Exploring innovative disease modeling platforms utilizing induced pluripotent stem cells (iPSCs)
A novel, scalable drug screening platform for neuromuscular diseases
Unveiling breakthroughs in growth factor technology to enhance reproducibility in neural stem cell research
Exploring future prospects and advancements in neural stem cell research

Speakers: Dr. Dammy Olayanju (Qkine), Dr. Ivo Lieberam (King's College London), Joshua Thomas (German Center for Neurodegenerative Diseases)